Vijaya Diagnostic Centre Limited has informed the Exchange about Investor Presentation
December 19, 2023
To, Listing Department National Stock Exchange Of India Limited, Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai- 400 051 NSE Symbol. VIJAYA
To, The Corporate Relations Department BSE Limited, Phiroz Jeejeebhoy Towers, 25th floor, Dalal Street, Mumbai - 400 001 BSE Scrip Code. 543350
Dear Sir/Madam,
Sub: Investor Presentation – “Acquisition”
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the presentation on the approval of the acquisition pursuant to the Board Meeting held today i.e., on December 19, 2023.
Please take the information on record.
Thanking you, For Vijaya Diagnostic Centre Limited
Hansraj Singh Company Secretary & Compliance Officer M. No. F11438
Encl.: As Above
Announcement of Acquisition
Safe Harbour
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded.
Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the Company’s ability to successfully implement its strategy, the Company's future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cashflows, the Company's market preferences and its exposure to market risks, as well as other risks. The Company's actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third-party statements and projections.
All Maps used in the Presentation are not to scale. All data, information and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness.
2
About the company
Disclaimer
PH is Pune’s largest B2C focused Integrated Diagnostic Chain, with a remarkable 23 year legacy of Trust.
PH was founded by Dr. Hemanth Dhoka in 2001, who is a Doctor by profession along with his family with a vision to deliver quality health care and convenience to the customer by providing all services under one roof.
3
Management comments
Commenting on the acquisition, Ms. Suprita Reddy, MD & CEO at Vijaya Diagnostic Centre Ltd. said:
“I am happy to announce the acquisition of P H Diagnostic, Pune’s largest B2C focused integrated diagnostic chain as part of our inorganic strategy.
This acquisition will enable us to establish our presence in the Western India, focusing particularly on the rapidly expanding metro city Pune.
Built by Dr. Hemant Dhoka on a similar commitment of delivering high quality and service standards, along with the philosophy of creating convenience to the customer by offering “All under one roof”, our cultural alignment presents an ideal foundation. With this synergy, I am optimistic that we can build dense integrated diagnostic networks across multiple cities in the Western India in the years to come.
PH has strong brand recognition, contributing to nearly 90% of its revenue from B2C, while also generating more than 15% of its revenue from the wellness segment.”
4
Key Highlights
Type of Facility
Services Available
Count
Hubs
Spokes
Collection Centres (Company run)
Collection Centres (Franchisee)
Total customer facing centres
Processing Laboratory
Type of Centres
Hubs
Spokes
Sample collection, Ultrasound, X-Ray, 2D Echo, BMD, MRI, CT etc.,
Sample collection, Ultrasound, X-Ray, 2D Echo etc.,
Sample collection only
Sample collection only
3
3
12
4
22
1
Current annual revenue rate per centre
~ INR 110 Mn +
~ INR 25 Mn +
Particulars
Revenue
EBITDA
FY 23
INR 416.3 Mn
Inline with Vijaya’s margin
Collection & Franchisee Centres
~ INR 2 Mn +
Business Proposition
Particulars
VIJAYA
P H
Revenue Mix %
- Radiology
- Pathology
Wellness Mix %
B2C Rev Mix %
36%
64%
13%
95%
~ 43% - 47%
~ 53% - 57%
~ 14% - 16%
~ 85% - 90%
Transaction Value
Particulars
Consideration for 100% Equity Shares (Secondary)
Payment towards Debt in the Target
Total Cost of acquisition of the Target
Mode of Payment
Rs Mn
1,347
128
1,475
Cash
Consultants appointed for the transaction
Consultant
Engagement
Deloitte
Financial & Tax Diligence
JSA Advocates & Solicitors
Legal Diligence
Price Waterhouse & Co. LLP
Transaction Structuring
RedSeer
Market Study
High Quality Infrastructure
9
Superior Facilities
10
State-of-the-art Medical Equipment
11
Customer Engagement
Home Collection
E Commerce Website
Call Centre
Whatsapp Chatbot
Corporate Tie-ups
12
Investors Conference call
Company will host a conference call shortly to discuss the acquisition of P H Diagnostic Centre Private Limited
13
Thank You
For further information please contact:
Mr. Siva Rama Raju Head – Strategy & Investor Relations +91 99485 95555
sivaramaraju.v@vijayadiagnostic.in ir@vijayadiagnostic.in
www.vijayadiagnostic.com
Corporate Office : #6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082, Telangana, India.